Semler Scientific, Inc. (NASDAQ:SMLR) Short Interest Update

Semler Scientific, Inc. (NASDAQ:SMLR - Get Free Report) was the target of a large growth in short interest in March. As of March 31st, there was short interest totalling 1,790,000 shares, a growth of 20.1% from the March 15th total of 1,490,000 shares. Based on an average daily trading volume, of 407,200 shares, the short-interest ratio is presently 4.4 days. Approximately 23.0% of the shares of the stock are sold short.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. Capital International Investors bought a new position in Semler Scientific in the fourth quarter worth approximately $30,813,000. Susquehanna Advisors Group Inc. bought a new position in shares of Semler Scientific during the 4th quarter worth $26,928,000. Driehaus Capital Management LLC bought a new position in shares of Semler Scientific during the 4th quarter worth $10,122,000. Thames Capital Management LLC purchased a new position in shares of Semler Scientific during the fourth quarter valued at $6,465,000. Finally, Invesco Ltd. bought a new position in shares of Semler Scientific during the fourth quarter valued at approximately $5,964,000. Hedge funds and other institutional investors own 49.37% of the company's stock.

Semler Scientific Trading Up 7.0 %

Shares of NASDAQ:SMLR traded up $2.40 during mid-day trading on Friday, reaching $36.84. The stock had a trading volume of 1,008,704 shares, compared to its average volume of 408,166. The business's 50 day moving average price is $37.11 and its 200 day moving average price is $46.10. Semler Scientific has a 1 year low of $20.88 and a 1 year high of $81.56. The company has a market cap of $353.55 million, a P/E ratio of 7.50 and a beta of 1.29.

Semler Scientific (NASDAQ:SMLR - Get Free Report) last released its quarterly earnings data on Tuesday, February 18th. The company reported $3.41 EPS for the quarter, beating the consensus estimate of $0.20 by $3.21. Semler Scientific had a net margin of 72.65% and a return on equity of 50.77%. The business had revenue of $12.41 million during the quarter.

Wall Street Analyst Weigh In

Separately, Lake Street Capital upped their price objective on Semler Scientific from $40.00 to $71.00 and gave the stock a "buy" rating in a research note on Friday, January 24th.

About Semler Scientific

Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition.